Dong Mei Su
Director/Board Member at 3SBIO INC.
Net worth: 19 M $ as of 30/05/2024
Profile
Dong Mei Su is currently the Executive Director & Senior Vice President at 3SBio, Inc. and the Director at Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd.
She previously held positions as the Director & Vice President at Shenyang Sunshine Pharmaceuticals Co., Ltd., Director at Strategic International Group Ltd., Director at Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., and Member-Supervisory Board at Liaoning Sunshine Bio-Pharmaceutical Co., Ltd.
and Liaoning Sunshine Science & Technology Development Co. Ltd.
Dr. Su's former jobs include being the Director at Hongkong Sansheng Medical Ltd.
and Director at Guangdong Sunshine Pharmaceutical Co., Ltd.
She obtained her undergraduate degree from Jilin University in 1992, her graduate degree from Shenyang Pharmaceutical University in 2001, and her doctorate degree from Shenyang Pharmaceutical University in 2010.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
3SBIO, INC.
1.00% | 29/06/2023 | 24,384,630 ( 1.00% ) | 19 M $ | 30/05/2024 |
Dong Mei Su active positions
| Companies | Position | Start |
|---|---|---|
| 3SBIO INC. | Director/Board Member | 10/06/2012 |
| SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD | Director/Board Member | 08/09/2022 |
| Liaoning Sunshine Bio-Pharmaceutical Co., Ltd. | Director/Board Member | 31/10/2006 |
| Liaoning Sunshine Science & Technology Development Co. Ltd. | Director/Board Member | 31/08/2009 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
 Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Director/Board Member | 31/12/1992 |
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd.
 Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of 3SBio, Inc., Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. is a Chinese bio-pharmaceutical company. The company is based in Dongguan, China. The company was founded in 2011. The CEO is Yong Xu. | Director/Board Member | 15/11/2018 |
Strategic International Group Ltd.
 Strategic International Group Ltd. Miscellaneous Commercial ServicesCommercial Services Strategic International Group Ltd. Provides financial services. The company is headquartered in London, the United Kingdom. | Director/Board Member | - |
Former positions of Dong Mei Su
| Companies | Position | End |
|---|---|---|
Hongkong Sansheng Medical Ltd.
 Hongkong Sansheng Medical Ltd. Pharmaceuticals: MajorHealth Technology Hongkong Sansheng Medical Ltd. develops and commercializes oral disintegration tablet formulation of antipruritic drug. The company is headquartered is Hong Kong. | Director/Board Member | 31/10/2014 |
Guangdong Sunshine Pharmaceutical Co., Ltd.
 Guangdong Sunshine Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2016, Guangdong Sunshine Pharmaceutical Co., Ltd. is a subsidiary of 3SBio, Inc. that manufactures and markets biopharmaceutical products. The company is based in Dongguan, China. | Director/Board Member | - |
Training of Dong Mei Su
| Shenyang Pharmaceutical University | Graduate Degree |
| Jilin University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| 3SBIO INC. | Health Technology |
| SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD | Health Technology |
| Private companies | 7 |
|---|---|
| Liaoning Sunshine Bio-Pharmaceutical Co., Ltd. | |
| Liaoning Sunshine Science & Technology Development Co. Ltd. | |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Health Technology |
Hongkong Sansheng Medical Ltd.
Hongkong Sansheng Medical Ltd. Pharmaceuticals: MajorHealth Technology Hongkong Sansheng Medical Ltd. develops and commercializes oral disintegration tablet formulation of antipruritic drug. The company is headquartered is Hong Kong. | Health Technology |
Guangdong Sunshine Pharmaceutical Co., Ltd.
Guangdong Sunshine Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2016, Guangdong Sunshine Pharmaceutical Co., Ltd. is a subsidiary of 3SBio, Inc. that manufactures and markets biopharmaceutical products. The company is based in Dongguan, China. | Health Technology |
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd.
Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of 3SBio, Inc., Guangdong Sciprogen Bio-Pharmaceutical Technology Co., Ltd. is a Chinese bio-pharmaceutical company. The company is based in Dongguan, China. The company was founded in 2011. The CEO is Yong Xu. | Health Technology |
Strategic International Group Ltd.
Strategic International Group Ltd. Miscellaneous Commercial ServicesCommercial Services Strategic International Group Ltd. Provides financial services. The company is headquartered in London, the United Kingdom. | Commercial Services |
- Stock Market
- Insiders
- Dong Mei Su
